Works matching IS 2160763X AND DT 2021 AND VI 10 AND IP 6
Results: 13
A Phase 1 Study to Investigate the Effects of Cortexolone 17α‐Propionate, Also Known as Clascoterone, on the QT Interval Using the Meal Effect to Demonstrate ECG Assay Sensitivity.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 572, doi. 10.1002/cpdd.935
- By:
- Publication type:
- Article
Evaluation of the CYP3A and CYP2B6 Drug‐Drug Interaction Potential of Lemborexant.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 681, doi. 10.1002/cpdd.915
- By:
- Publication type:
- Article
Pharmacokinetics of Gepotidacin in Subjects With Normal Hepatic Function and Hepatic Impairment.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 588, doi. 10.1002/cpdd.913
- By:
- Publication type:
- Article
Phase 1 Study of the Effects of the Tuberculosis Treatment Pretomanid, Alone and in Combination With Moxifloxacin, on the QTc Interval in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 634, doi. 10.1002/cpdd.898
- By:
- Publication type:
- Article
Safety, Pharmacokinetics, and Pharmacodynamics of a Dipeptidyl Peptidase‐4 Inhibitor: A Randomized, Double‐Blinded, Placebo‐Controlled Daily Administration of Fotagliptin Benzoate for 14 Days for Type 2 Diabetes Mellitus.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 660, doi. 10.1002/cpdd.895
- By:
- Publication type:
- Article
Safety, Tolerability, and Pharmacokinetics of Tazarotene Clindamycin Cream: A Single‐Dose, 3‐Period Crossover Study.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 598, doi. 10.1002/cpdd.890
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 567, doi. 10.1002/cpdd.713
- Publication type:
- Article
Pharmacokinetics of Belimumab in Children With Systemic Lupus Erythematosus.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 622, doi. 10.1002/cpdd.889
- By:
- Publication type:
- Article
A Phase 1 Dose‐Escalation Study of Low‐Dose Metronomic Treatment With Novel Oral Paclitaxel Formulations in Combination With Ritonavir in Patients With Advanced Solid Tumors.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 607, doi. 10.1002/cpdd.880
- By:
- Publication type:
- Article
Pharmacokinetics of Ginsenoside Rh2, the Major Anticancer Ingredient of Ginsenoside H Dripping Pills, in Healthy Subjects.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 669, doi. 10.1002/cpdd.877
- By:
- Publication type:
- Article
Effect of Food Intake on the Pharmacokinetics of the Selective Progesterone Receptor Modulator Vilaprisan: A Randomized Clinical Study in Healthy Postmenopausal Women.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 675, doi. 10.1002/cpdd.876
- By:
- Publication type:
- Article
Bioequivalence and Evaluation Parameters Based on the Pharmacodynamics of Miglitol in Healthy Volunteers.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 582, doi. 10.1002/cpdd.873
- By:
- Publication type:
- Article
Pharmacokinetics of Deutetrabenazine and Tetrabenazine: Dose Proportionality and Food Effect.
- Published in:
- Clinical Pharmacology in Drug Development, 2021, v. 10, n. 6, p. 647, doi. 10.1002/cpdd.882
- By:
- Publication type:
- Article